Raymond James & Associates’s Incyte INCY Stock Holding History
Bought
Maintained
Sold
Other funds holding INCY
BBA
Raymond James & Associates's INCY Position: Q3 2024 in Review
Raymond James & Associates reduced its Incyte (INCY) stake by 21% in Q3 2024, selling an estimated $464K and leaving 27,511 shares worth $1.82M. The position accounts for ﹤0.01% of the portfolio, ranked #2290.
Raymond James & Associates first reported a position in INCY in Q2 2013 and has held it in 42 quarters since. The position peaked at $21.1M in Q2 2019. 592 funds tracked by Wall St. Rank hold INCY as of Q3 2024.
- Raymond James & Associates held 27,511 shares of Incyte worth $1.82M as of Q3 2024.
- Raymond James & Associates sold 7,279 Incyte shares in Q3 2024, an estimated $464K.
- Incyte made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2290 holding.
- Raymond James & Associates first reported a position in Incyte in Q2 2013 and has held it in 42 quarters since.
- Raymond James & Associates's Incyte position peaked at $21.1M in Q2 2019.
- 592 funds tracked by Wall St. Rank held Incyte as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.